UK

As expected, no euro issuers were tempted to compete with the European Central Bank meeting on Thursday, however British Land took the opportunity to bring its first senior bond since 2006.

Nationwide Building Society was looking to cement the outstanding secondary market performance of its £550m core capital deferred shares (CCDS) by issuing roughly £500m more of the rare product on Thursday.

Axel Weber, chairman of UBS, warned ahead of the European Central Bank (ECB) meeting on Thursday that “unknown unknowns” lie in wait for markets once the course of unwinding quantitative easing begins.

Intercontinental Exchange (ICE) on Wednesday announced a spate of changes to its senior management, all due to be enacted in October, including the replacement of veteran president of ICE Futures Europe David Peniket with Stuart Williams.

United Biscuits’ £725m ($948.23m) loan is being split into two term loans and a revolving credit facility with pricing linked to the company’s leverage, according to a banker on the deal.

Clarion Events is set to launch the loan funding for its acquisition by private equity firm Blackstone next week or soon after. The buyer also has funding for a deal to buy Paysafe in the pipeline.

Yorkshire Building Society (YBS) opened books on new tier two in the sterling market on Wednesday, as it considered whether difficulties in the process of changing to a new way of modelling for risk could leave it short of its minimum requirement for own funds and eligible liabilities (MREL).

Crédit Agricole CIB, the investment banking arm of the larger French bank, has hired a market veteran from Société Générale as global head of debt capital markets solutions and advisory.

Niche players see MiFID II's research rules as an opportunity to win market share.

The UK Debt Management Office (DMO) tapped a 2065 line for £4bn on Tuesday, upping the size of the transaction because of “impressive quality of demand”.

Monday’s combination of heightened worries over North Korea and the Labor Day holiday in the US saw only one new issue in the European corporate bond market. However, with no new developments from the Korean peninsula overnight, five issuers decided to push ahead with trades on Tuesday.

On Tuesday, pharmaceutical firm GlaxoSmithKline returned to the corporate bond market for the first time since November 2014, and its rarity value contributed to combined order books of over €5.5bn for the triple tranche deal.